Fibrillar Collagen Specifically Regulates Human Vascular Smooth Muscle Cell Genes Involved in Cellular Responses and the Pericellular Matrix Environment

Abstract— Proliferation and &agr;v&bgr;3 integrin-dependent migration of vascular smooth muscle cells are suppressed on polymerized type I collagen. To identify genes specifically regulated in human smooth muscle cells by polymerized collagen, we used the suppressive subtraction hybridization technique. Compared with smooth muscle cells cultured on monomer collagen, polymerized collagen suppresses the following: (1) a number of other extracellular matrix proteins, including fibronectin, thrombospondin-1, tenascin-C, and cysteine-rich protein 61; (2) actin binding proteins including &agr;-actinin; (3) signaling molecules; (4) protein synthesis-associated proteins; and (5) genes with unknown functions. Some of the identified genes, including cysteine-rich protein 61, show unique kinetics of mRNA regulation by monomer or polymerized collagen distinct from growth factors, suggesting extracellular matrix-specific gene modulation. Moreover, in vivo balloon catheter-mediated injury to the rat carotid artery induces many of the genes that are suppressed by polymerized collagen. Protein levels of thrombospondin-1 and fibronectin are also suppressed by polymerized collagen. Thrombospondin-1-mediated smooth muscle cell migration on vitronectin is significantly inhibited after culture on polymerized collagen for 24 hours, which is associated with decreased &agr;-actinin accumulation at focal adhesions. Thus, polymerized type I collagen dynamically regulates gene expression, pericellular accumulation of extracellular matrix molecules, and the response to a given matrix molecule.

[1]  H. Deckmyn,et al.  Inhibition of integrin function by a cyclic RGD-containing peptide prevents neointima formation. , 1994, Circulation.

[2]  A. Ben-Ze'ev,et al.  Modulation of α-actinin levels affects cell motility and confers tumorigenicity on 3 T 3 cells , 2022 .

[3]  C. Alpers,et al.  αvβ3 Integrin Expression in Normal and Atherosclerotic Artery , 1995 .

[4]  James M. Roberts,et al.  Fibrillar Collagen Inhibits Arterial Smooth Muscle Proliferation through Regulation of Cdk2 Inhibitors , 1996, Cell.

[5]  A. Ben-Ze'ev,et al.  Modulation of alpha-actinin levels affects cell motility and confers tumorigenicity on 3T3 cells. , 1994, Journal of cell science.

[6]  C. Giachelli,et al.  Phosphorylation of Osteopontin Is Required for Inhibition of Vascular Smooth Muscle Cell Calcification* , 2000, The Journal of Biological Chemistry.

[7]  U. Hedin,et al.  Induction of tenascin in rat arterial injury. Relationship to altered smooth muscle cell phenotype. , 1991, The American journal of pathology.

[8]  Richard O. Hynes,et al.  Integrins: Versatility, modulation, and signaling in cell adhesion , 1992, Cell.

[9]  S. Kanner,et al.  Filamin binds to the cytoplasmic domain of the beta1-integrin. Identification of amino acids responsible for this interaction. , 1998, The Journal of biological chemistry.

[10]  D. Erle,et al.  Integrin β Cytoplasmic Domains Differentially Bind to Cytoskeletal Proteins* , 1998, The Journal of Biological Chemistry.

[11]  N. Carragher,et al.  Degraded Collagen Fragments Promote Rapid Disassembly of Smooth Muscle Focal Adhesions That Correlates with Cleavage of Pp125FAK, Paxillin, and Talin , 1999, The Journal of cell biology.

[12]  A. Callow,et al.  Inhibition of neointimal hyperplasia by blocking αvβ3 integrin with a small peptide antagonist GpenGRGDSPCA , 1994 .

[13]  R. Ross,et al.  The adhesive and migratory effects of osteopontin are mediated via distinct cell surface integrins. Role of alpha v beta 3 in smooth muscle cell migration to osteopontin in vitro. , 1995, The Journal of clinical investigation.

[14]  A. Hughes,et al.  Thrombospondin-1 is a potent mitogen and chemoattractant for human vascular smooth muscle cells. , 1997, Arteriosclerosis, thrombosis, and vascular biology.

[15]  R. Ross,et al.  Dynamic expression of alpha 1 beta 1 and alpha 2 beta 1 integrin receptors by human vascular smooth muscle cells. Alpha 2 beta 1 integrin is required for chemotaxis across type I collagen-coated membranes. , 1994, The American journal of pathology.

[16]  E. Danen,et al.  Integrin signaling: cytoskeletal complexes, MAP kinase activation, and regulation of gene expression. , 1998, Cell adhesion and communication.

[17]  S. Fukumoto,et al.  Distinct role of cAMP and cGMP in the cell cycle control of vascular smooth muscle cells: cGMP delays cell cycle transition through suppression of cyclin D1 and cyclin-dependent kinase 4 activation. , 1999, Circulation research.

[18]  N. Carragher,et al.  The Extracellular Matrix Dynamically Regulates Smooth Muscle Cell Responsiveness to PDGF a , 2000, Annals of the New York Academy of Sciences.

[19]  A. Vaheri,et al.  Fibronectin and atherosclerosis. , 2009, Acta medica Scandinavica. Supplementum.

[20]  M. Mayberg,et al.  Thrombospondin deposition in rat carotid artery injury. , 1990, The American journal of pathology.

[21]  C. Bauters,et al.  Accumulation of fetal fibronectin mRNAs after balloon denudation of rabbit arteries. , 1995, Circulation.

[22]  J. Thyberg,et al.  Diverse effects of fibronectin and laminin on phenotypic properties of cultured arterial smooth muscle cells , 1988, The Journal of cell biology.

[23]  P. Bornstein,et al.  Light microscopic immunolocation of thrombospondin in human tissues. , 1985, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[24]  E. Krebs,et al.  Insulin-like growth factor-I and platelet-derived growth factor-BB induce directed migration of human arterial smooth muscle cells via signaling pathways that are distinct from those of proliferation. , 1994, The Journal of clinical investigation.

[25]  S. Fukumoto,et al.  The fumagillin analogue TNP-470 inhibits DNA synthesis of vascular smooth muscle cells stimulated by platelet-derived growth factor and insulin-like growth factor-I. Possible involvement of cyclin-dependent kinase 2. , 1996, Circulation research.

[26]  E. Nabel,et al.  Expression of cyclin-dependent kinase inhibitors in vascular disease. , 1998, Circulation research.

[27]  S. Kaul,et al.  Tenascin-C is expressed in macrophage-rich human coronary atherosclerotic plaque. , 1999, Circulation.

[28]  M. I. Lomax,et al.  A gene upregulated in the acoustically damaged chick basilar papilla encodes a novel WD40 repeat protein. , 1999, Genomics.

[29]  V. Challa,et al.  Cerebrovascular Pathology in Alzheimer's Disease and Leukoaraiosis , 2000, Annals of the New York Academy of Sciences.

[30]  K. Burridge,et al.  An Interaction between a-Actinin and the/ 1 Integrin Subunit In Vitro , 1990 .

[31]  K. Burridge,et al.  An interaction between alpha-actinin and the beta 1 integrin subunit in vitro , 1990, The Journal of cell biology.

[32]  R. Ross.  The pathogenesis of atherosclerosis: a perspective for the 1990s , 1993, Nature.

[33]  Shokei Kim,et al.  Angiotensin II type 1 receptor blockade inhibits the expression of immediate-early genes and fibronectin in rat injured artery. , 1995, Circulation.

[34]  M. Schwartz,et al.  Integrins: emerging paradigms of signal transduction. , 1995, Annual review of cell and developmental biology.

[35]  U. Ryan,et al.  Thrombospondin mediates migration and potentiates platelet‐derived growth factor‐dependent migration of calf pulmonary artery smooth muscle cells , 1993, Journal of cellular physiology.